We “Happy-call” think the best for our customers is to give them trust and sincerity.
Home > Regulatory Affairs
Even if safety and efficacy are proved,
- ① War-nings in the label should be rechecked and approval standard should be reconsidered after
- ② The drug needs to be reviewed to prevent risk factors
- ① The drug is already stated in the Korean and U.S. Pharmacopeia, obtaining safety and efficacy approval
- ② Proper pre-management is enough